SABBY 13G ATNM 5.01.20

Company

Actinium Pharmaceuticals, Inc.

Filed

May 1, 2020

Accession Number

0001535610-20-000091

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →